Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 20/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7933364 | 0.94 | ADORA1 (0.55) | ADORA1ADORA3ADORA2BADORA2A | |
| SCHEMBL7940578 | 0.92 | ADORA1 (0.66) | ADORA1ADORA3ADORA2BADORA2A | |
| SCHEMBL7938934 | 0.87 | ADORA1 (0.56) | ADORA1ADORA3ADORA2BADORA2A | |
| SCHEMBL7939581 | 0.85 | ADORA1 (0.66) | ADORA1ADORA3ADORA2BADORA2A | |
| SCHEMBL7937616 | 0.85 | ADORA1 (0.54) | ADORA1ADORA3ADORA2BADORA2A | |
| SCHEMBL7939804 | 0.82 | ADORA1 (0.60) | ADORA1ADORA3ADORA2BADORA2A | |
| SCHEMBL7942415 | 0.81 | ADORA1 (0.60) | ADORA1ADORA3ADORA2BADORA2A | |
| SCHEMBL7937178 | 0.81 | ADORA1 (0.60) | ADORA1ADORA3ADORA2BADORA2A | |
| SCHEMBL7939113 | 0.81 | ADORA1 (0.57) | ADORA1ADORA3ADORA2BADORA2A | |
| SCHEMBL7938634 | 0.81 | ADORA1 (0.83) | ADORA1ADORA3ADORA2BADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010020366-A1 | AZABICYCLIC SUBSTITUTED 5-AMINOPYRAZOLES AND THE USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-02-25 | — | — | WO | disclosed |
| WO-2010020366-A1 | AZABICYCLIC SUBSTITUTED 5-AMINOPYRAZOLES AND THE USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-02-25 | — | — | WO | disclosed |